Asper Ophthalmics
Asper Ophthalmics is a division of Asper Biotech. Asper Biotech has developed a number of DNA testing applications during its operations, and since the scope of the business has been growing, we feel we need to focus on the most important areas of our business.
Together with our partners, we have developed a portfolio of ophthalmic DNA tests. This list will continue to expand in the coming years. We created Asper Ophthalmics because ophthalmics has become a major part of our operations, and we see an increasing potential in the future.
Asper Ophthalmics combines the experience and reputation of our partners and the high quality DNA testing company Asper Biotech with our increasing focus on ophthalmics.
We wish to be the partner of choice for all those involved: ophthalmics genetic research institutions, DNA testing centers, patient organizations, and commercial entities.
Panel of genetic eye disease tests
- Stargardt Disease, Cone-Rod Dystrophy – ABCA4
- Autosomal Dominant Retinitis Pigmentosa – AD RP
- Autosomal Recessive Retinitis Pigmentosa – AR RP
- X-Linked Retinitis Pigmentosa – XL-RP
- Leber Congenital Amaurosis – LCA
- Bardet Biedl Syndrome, McKusick-Kaufman Syndrome, Borjeson-Forssman-Lehmann Syndrome, Alström Syndrome, Albright Hereditary Osteodystrophy
- Vitelliform Macular Dystrophy – BEST-VMD
- Congenital Stationary Night Blindness – CSNB
- Corneal Dystrophy – Cornea
- Autosomal Dominant Optic Atrophy – OPA-1 ADOA
- Age-Related Macular Degeneration – AMD
- Usher Syndrome
|
